<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
NGM
NGM Biopharmaceuticals
$
()


  • One new option listing and thirteen option delistings on April 23rd

    4/23/2024 - 08:31am
  • Oracle, Dollar General upgraded: Wall Street's top analyst calls

    3/12/2024 - 09:51am
  • NGM downgraded to Market Perform from Outperform at Raymond James

    3/12/2024 - 04:44am
  • NGM Biopharmaceuticals reports Q4 EPS (33c), consensus (39c)

    3/11/2024 - 16:22pm
  • NGM Biopharmaceuticals just downgraded at TD Cowen, here's why

    2/27/2024 - 18:00pm
  • NGM Biopharmaceuticals just downgraded at Citi, here's why

    2/27/2024 - 08:49am
  • NGM Biopharmaceuticals trading resumes

    2/26/2024 - 09:50am
  • NGM to be acquired by affiliates of The Column Group for $1.55 per share

    2/26/2024 - 09:07am
  • NGM Biopharmaceuticals trading halted, news pending

    2/26/2024 - 08:50am
  • NGM announces new data from NGM707 trial, outlines strategies for candidates

    1/9/2024 - 08:14am
  • Biotech Alert: Searches spiking for these stocks today

    1/5/2024 - 11:01am
  • Biotech Alert: Searches spiking for these stocks today

    1/4/2024 - 11:13am
  • NGM Biopharma confirms The Column Group interested in acquiring company

    1/4/2024 - 11:06am
  • NGM Biopharmaceuticals' aldafermin granted orphan status

    12/21/2023 - 13:11pm
  • NGM Biopharmaceuticals price target lowered to $3.50 from $7.00 at B. Riley

    11/22/2023 - 08:28am
dynamic_feed Breaking News